hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide)

C348H408N96O32S16 — CID 163866608

IUPAChexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide)
SMILESCO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1ccccc1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1ccccc1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1ccccc1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1ccccc1
InChIInChI=1S/12C22H26N6O2S.4C21H24N6O2S/c12*1-14-5-3-6-16(13-14)19(30-2)20(29)25-22-28-27-21(31-22)24-17-10-8-15(9-11-17)18-7-4-12-23-26-18;4*1-29-18(15-6-3-2-4-7-15)19(28)24-21-27-26-20(30-21)23-16-11-9-14(10-12-16)17-8-5-13-22-25-17/h12*3-7,12-13,15,17,19H,8-11H2,1-2H3,(H,24,27)(H,25,28,29);4*2-8,13-14,16,18H,9-12H2,1H3,(H,23,26)(H,24,27,28)/t12*15?,17?,19-;4*14?,16?,18-/m1111110000001100/s1
InChIKeyPHEIBQFOWREOBB-RSLLJOQKSA-N
MW6960.80 g/mol
LogP64.38
Rot. Bonds112

About hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide)

hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide) (PubChem CID 163866608) has the molecular formula C348H408N96O32S16 and a molecular weight of 6960.80 g/mol. Its IUPAC name is hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide).

Molecular Properties

Compound Namehexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide)
PubChem CID163866608
Molecular FormulaC348H408N96O32S16
Molecular Weight6960.80 g/mol
Exact Mass6954.88
IUPAC Namehexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide)
SMILESCO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1ccccc1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1ccccc1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1ccccc1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1ccccc1
InChIInChI=1S/12C22H26N6O2S.4C21H24N6O2S/c12*1-14-5-3-6-16(13-14)19(30-2)20(29)25-22-28-27-21(31-22)24-17-10-8-15(9-11-17)18-7-4-12-23-26-18;4*1-29-18(15-6-3-2-4-7-15)19(28)24-21-27-26-20(30-21)23-16-11-9-14(10-12-16)17-8-5-13-22-25-17/h12*3-7,12-13,15,17,19H,8-11H2,1-2H3,(H,24,27)(H,25,28,29);4*2-8,13-14,16,18H,9-12H2,1H3,(H,23,26)(H,24,27,28)/t12*15?,17?,19-;4*14?,16?,18-/m1111110000001100/s1
InChIKeyPHEIBQFOWREOBB-RSLLJOQKSA-N
XLogP64.38
TPSA1630.72 Ų
H-Bond Donors32
H-Bond Acceptors128
Rotatable Bonds112
Heavy Atoms492
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5006960.80
LogP ≤ 564.38
H-Bond Donors ≤ 532
H-Bond Acceptors ≤ 10128

Analyze hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[3-(difluoromethoxy)phenyl]-2-methoxy-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide
CID 166957535
(2S)-2-(4-fluoro-3-methylphenyl)-2-methoxy-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide
CID 163714855
bis((2R)-2-methoxy-2-(3-methoxyphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)methyl]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-(3-methoxyphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)methyl]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)methyl]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)methyl]-1,3,4-thiadiazol-2-yl]acetamide)
CID 163551655
2-methoxy-2-phenyl-N-[5-[[1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide
CID 123401266
1-methoxy-1-phenyl-3-[5-[(4-pyridazin-3-ylcyclohexyl)methyl]-1,3,4-thiadiazol-2-yl]propan-2-one
CID 163920790
2-(3,5-dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide
CID 154584195
(2R)-2-ethoxy-2-phenyl-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide
CID 118542694
(2S)-2-ethoxy-2-phenyl-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide
CID 118554607
(2S)-2-[3-(3,3-difluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide
CID 129161444
(2R)-2-[3-(3,3-difluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide
CID 129161462
2-cyclohexa-1,5-dien-1-yl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide
CID 167282023
(2R)-2-(4-fluorophenyl)-2-methoxy-N-[5-[[(3R)-1-(5-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide
CID 129161600

Frequently Asked Questions

What is the IUPAC name of hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide)?
The IUPAC name of hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide) (CID 163866608) is hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide).
What is the SMILES notation for hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide)?
The canonical SMILES for hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide) is CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1ccccc1.CO[C@@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1ccccc1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1cccc(C)c1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1ccccc1.CO[C@H](C(=O)Nc1nnc(NC2CCC(c3cccnn3)CC2)s1)c1ccccc1.
What is the InChIKey of hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide)?
The InChIKey is PHEIBQFOWREOBB-RSLLJOQKSA-N. The full InChI is InChI=1S/12C22H26N6O2S.4C21H24N6O2S/c12*1-14-5-3-6-16(13-14)19(30-2)20(29)25-22-28-27-21(31-22)24-17-10-8-15(9-11-17)18-7-4-12-23-26-18;4*1-29-18(15-6-3-2-4-7-15)19(28)24-21-27-26-20(30-21)23-16-11-9-14(10-12-16)17-8-5-13-22-25-17/h12*3-7,12-13,15,17,19H,8-11H2,1-2H3,(H,24,27)(H,25,28,29);4*2-8,13-14,16,18H,9-12H2,1H3,(H,23,26)(H,24,27,28)/t12*15?,17?,19-;4*14?,16?,18-/m1111110000001100/s1.
What are the key properties of hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide)?
hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide) has a molecular weight of 6960.80 g/mol, XLogP of 64.38, 112 rotatable bonds, 32 hydrogen bond donors, and 128 hydrogen bond acceptors.
Where does this data come from?
All data for hexakis((2R)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);hexakis((2S)-2-methoxy-2-(3-methylphenyl)-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2R)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide);bis((2S)-2-methoxy-2-phenyl-N-[5-[(4-pyridazin-3-ylcyclohexyl)amino]-1,3,4-thiadiazol-2-yl]acetamide) is sourced from PubChem (CID 163866608), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).